LOS ALTOS, CA, Alto Neuroscience, a mental health therapeutics startup, announced its emergence from stealth with $40 million in funding.
Alto Neuroscience, a mental health therapeutics startup, announced its emergence from stealth with $40 million in funding to advance the largest clinical-stage pipeline of precision psychiatry medicines.
The round was led by Apeiron Investment Group, and included Windham Venture Partners, What If Ventures, Able Partners, Risk and Return, Tim Kendall, and other unnamed investors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
